Ketamine, GHB and GBL

Two very different substances sharing one problem: the gap between the dose that works and the dose that knocks you out is tiny — and GHB can be slipped into a drink without the person knowing (Drogues Info Service).

Appear on this page

Get our daily news watch

Where the substance comes from

Ketamine is a veterinary and human anaesthetic, diverted from legal medical supply or made in South-East Asia. GHB is synthetic; GBL, its industrial precursor, is a solvent sold as a stain remover or wheel cleaner, which the body converts to GHB within minutes — the same substance, more concentrated and less controllable.

A little history

Ketamine was synthesised in 1962 by Calvin Stevens at Parke-Davis as a replacement for phencyclidine (PCP), judged too delirium-inducing; tested on volunteer prisoners in 1964 and approved in 1970, it became the anaesthetic of the Vietnam battlefields because it neither drops blood pressure nor stops breathing. It is still on the WHO list of essential medicines. Its diverted use began in the 1970s on the American west coast, then in the clubs of the 1990s under the name "Special K". Since 2019 a nasal form, esketamine, has been approved for treatment-resistant depression.

A chemist examines a glass flask in a 1960s pharmaceutical laboratory
Ketamine was born in 1962 in a pharmaceutical laboratory, as an anaesthetic; GHB was studied in Paris in 1960 by Henri Laborit. Both retain a medical use.

GHB has an older history: synthesised in 1874 by the Russian chemist Alexander Zaytsev, it was only studied in 1960-1961 by Henri Laborit in Paris, who was looking for an anaesthetic close to the neurotransmitter GABA. Sold as a bodybuilding supplement in the 1980s, banned by the FDA in 1990 after comas, it became in the 1990s the "date-rape drug" of the news, then the drug of chemsex and clubs, often in the form of its industrial precursor, GBL.

GHB is controlled internationally under the 1971 Convention on Psychotropic Substances (GOV.UK, 2013), while ketamine is controlled country by country; both have kept a legitimate medical use, which explains why they circulate easily.

The forms it takes

What the user is looking for

With ketamine, dissociation: the body recedes, sensation distorts, time comes apart. With GHB, an effect close to alcohol without the tiredness: euphoria, disinhibition, a sought-after aphrodisiac effect. Both are common in party settings and in chemsex.

Immediate unwanted effects

Medium and long-term risks

In a hospital room, a nurse talks calmly with a young man sitting on the edge of the bed
GHB withdrawal can be severe: it is best prepared with medical help.

Regular ketamine destroys the bladder: frequency, pain, bleeding, sometimes a bladder reduced to a few tens of millilitres and surgery in very young people. It also causes violent abdominal pain and memory problems. Regular GHB use can lead to dependence and a severe withdrawal syndrome (Drogues Info Service) — anxiety, agitation, tremor, insomnia, hallucinations, sometimes delusional episodes: stopping is best prepared with medical help rather than alone.

How to spot use

Small bottles of colourless liquid, pipettes or needleless syringes, waking with no memory of the end of the evening, unexplained falls, urinary symptoms in a young adult, brief repeated disorientation.

Why the effect is stronger in adolescents

A school nurse leads a prevention session with final-year students
Use established before the age of eighteen multiplies the risk of dependence in adulthood, whatever the substance: that is what prevention in school is about.

At the same dose in a lighter body, the concentration reached is higher in an adolescent than in an adult. More importantly, the reward circuit matures well before the prefrontal cortex that is supposed to restrain it: the pull to repeat is stronger and the brake weaker, which markedly shortens the gap between first use and problem use. Use established before eighteen multiplies the risk of adult dependence whatever the substance — including legal ones such as the caffeine in energy drinks, alcohol or nicotine.

When to call an ambulance without hesitating

Loss of consciousness, seizures, severe confusion, slow or irregular breathing, blue lips, chest pain, very high temperature, uncontrollable agitation, suicidal thoughts. In those situations call the emergency services and say what was taken: treatment depends on it.

← Back : Drugs and addiction Getting help: who to turn to →

Sources

  1. GHB — Drogues Info Service, French public drug information service (Santé publique France), accessed 2026 (in French)
  2. Soumission chimique : résultats de l'enquête 2024 — French medicines safety agency (ANSM) and French addictovigilance network (CEIP-A), 2026 (in French): annual national survey: sedative medicines predominate (59.6% of mentions in 2024), MDMA the leading single agent for the 4th year
  3. ACMD advice on the scheduling of GHB (letter of 3 October 2013) — UK Government (GOV.UK), 2013: GHB is controlled under the 1971 Convention on Psychotropic Substances (moved from Schedule IV to Schedule II)

Official or institutional documents this page relies on, consulted on 12 October 2026. Links open in a new tab.

Page checked in . The instruments cited can change: if in doubt, confirm with the official source given.

Text prepared with artificial intelligence, reviewed and checked by the AffectionPlus team (method and sources: About). This content does not replace medical or legal advice. Spotted an error? Write to us.

Locate this page in the site map